Neutral/Negative Catalysts
- Weak technicals: Downside momentum is still increasing (MACD deteriorating), so “oversold” can stay oversold.
- No recent news in the last week; lack of fresh catalysts can limit upside follow-through.
- Longer catalyst horizon: The highlighted trial readout timing is mid-to-late 2027, which is not supportive for near-term demand.
- Positioning/trends: Hedge funds and insiders are reported as neutral (no supportive accumulation trend).